In vitro physicochemical characterization and short term in vivo tolerability study of ethionamide loaded PLGA nanoparticles: potentially effective agent for multidrug resistant tuberculosis

References

• Allemann E, Gurny R, Doelker E. Preparation of aqueous polymeric nanodispersions by a reversible salting-out process: Influence of process parameters on particle size. Int J Pharmacol 1992; 87: 247–54
   Google Scholar
• Auclair B, Nix DE, Adam RD, James GT, Peloquin CA. Pharmacokinetics of ethionamide administered under fasting conditions or with orange juice, food, or antacids. Antimicrob Agents Chemother 2001; 45: 810–4
   PubMed Web of Science ®Google Scholar
• Bass Jr JB, Jr, Farer LS, Hopewell PC, O' Brien R, Jacobs RF, Ruben F, Snider DE, Jr, Thornton G. Treatment of tuberculosis and tuberculosis infection in adults and children. American thoracic society and the centers for disease control and prevention. Am J Crit Care Med 1994; 149: 1359–74
   Google Scholar
• Bodmeier R, McGinity JW. The preparation and evaluation of drug containing poly (dl-lactide)microspheres formed by the solvent evaporation method. Pharm Res 1987; 4: 465–71
   PubMed Web of Science ®Google Scholar
• Budhian A, Siegel SJ, Winey KI. Haloperidol-loaded PLGA nanoparticles: Systematic study of particle size and drug content. Int J Pharm 2007; 336: 367–75
   PubMed Web of Science ®Google Scholar
• Champion JA, Mitragotri S. Shape induced inhibition of phagocytosis of polymer particles. Pharm Res 2009; 26: 244–9
   PubMed Web of Science ®Google Scholar
• Florence AT. The oral absorption of micro- and nanoparticulates: Neither exceptional nor unusal. Pharm Res 1997; 14: 259–66
   PubMed Web of Science ®Google Scholar
• Florence AT, Jani PU. Particulate delivery: The challenge of the oral route. Pharmaceutical particulate carriers: Therapeutic applications, A Rolland. Marcel Dekker, New York 1993; 82
   Google Scholar
• Hall JB, Dobrovolskaia MA, McNeil SE. Characterization of nanoparticles for therapeutics. Nanomedicine 2007; 2: 789–803
   PubMed Web of Science ®Google Scholar
• Hariharan S, Bhardwaj V, Bala I, Sitterberg J, Bakowsky U, Ravi Kumar MNV. Design of estradiol loaded PLGA nanoparticulate formulations: A potential oral delivery system for hormone therapy. Pharm Res 2006; 23: 184–95
   PubMed Web of Science ®Google Scholar
• Italia JL, Yahya MM, Singh D, Ravi Kumar MNV. Biodegradable nanoparticles improve oral bioavailabilty of Amphotericin B and show reduced nephrotoxicity compared to intravenous fungizone. Pharm Res 2009; 26: 1324–31
   PubMed Web of Science ®Google Scholar
• James GT, MeCarthy E. Improved high performance liquid chromatographic assay for the determination of ethionamide in serum. J Chromatography 1991; 563: 472–5
   PubMed Web of Science ®Google Scholar
• Jani P, Halbert GW, Langridge J, Florence AT. Nanoparticle uptake by the rat gastrointestinal mucosa: Quantitation and particle size dependency. J Pharm Pharmacol 1990; 42: 821–6
   PubMed Web of Science ®Google Scholar
• Jenkins PG, Howard KA, Blackhall NW, Thomas NW, Davis SS, O’Hagan DT. Microparticle absorption from rat intestine. J Control Release 1994; 29: 339–50
   Web of Science ®Google Scholar
• Kumar G, Sharma S, Shafiq N, Pandhi P, Khuller GK, Malhotra S. Pharmacokinetics and tissue distribution studies of orally administered nanoparticles encapsulated ethionamide used as potential drug delivery system in management of multi-drug resistant tuberculosis. Drug Deliv 2011; 18: 65–73
   PubMed Web of Science ®Google Scholar
• Lamprecht A, Ubrich N, Yamamoto H, Schafer U, Takeuchi H, Lehr CM, Maincent P, Kawashima Y. Design of rolipram-loaded nanoparticles: Comparison of two preparation methods. J Control Release 2001a; 71: 297–306
   PubMed Web of Science ®Google Scholar
• Lamprecht A, Ubrich N, Yamamoto H, Schafer U, Takeuchi H, Maincent P, Kawashima Y, Lehr CM. Biodegradable nanoparticles for targeted drug delivery in treatment of inflammatory bowel disease. J Pharmacol Exp Ther 2001b; 299: 775–81
   PubMed Web of Science ®Google Scholar
• Mainardes RM, Evangelista RC. PLGA nanoparticles containing praziquantel: Effect of formulation variables on size distribution. Int J Pharm 2005; 290: 137–44
   PubMed Web of Science ®Google Scholar
• Martin A, Camacho M, Portaels F, Palomino JC. Resazurin microtiter assay plate testing of Mycobacterium tuberculosis susceptibilities to second-line drugs: Rapid, simple, and inexpensive method. Antimicrob Agents Chemother 2003; 47: 3616–9
   PubMed Web of Science ®Google Scholar
• Nahar M, Mishra D, Dubey V, Jain NK. Development, characterization, and toxicity evaluation of amphotericin B-loaded gelatin nanoparticles. Nanomedicine 2008; 4: 252–61
   PubMed Web of Science ®Google Scholar
• O’Hagan DT. Intestinal translocation of particulates-implications for drug and antigen delivery. Adv Drug Deliver Rev 1990; 5: 265–85
   Google Scholar
• Pandey R, Khuller GK. Subcutaneous nanoparticle-based antitubercular chemotherapy in an experimental model. J Antimicrob Chemother 2004; 54: 266–8
   PubMed Web of Science ®Google Scholar
• Pandey R, Sharma A, Zahoor A, Sharma S, Khuller GK, Prasad B. Poly (DL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis. J Antimicrob Chemother 2003a; 52: 981–6
   PubMed Web of Science ®Google Scholar
• Pandey R, Zahoor A, Sharma S, Khuller GK. Nanoparticle encapsulated antitubercular drugs as a potential oral drug delivery system against murine tuberculosis. Tuberculosis 2003b; 83: 373–8
   PubMed Web of Science ®Google Scholar
• Rojas J, Pinto-Alphandary H, Leo E, Pecquet S, Couvreur P, Fattal E. Optimization of the encapsulation and release of beta-lactoglobulin entrapped poly (DL-lactide-co-glycolide) microspheres. Int J Pharm 1999; 183: 67–71
   PubMed Web of Science ®Google Scholar
• Sahana DK, Mittal G, Bhardwaj V, Ravi Kumar MNV. PLGA nanoparticles for oral delivery of hydrophobic drugs: Influence of organic solvent on nanoparticle formation and release behavior in vitro and in vivo using estradiol as a model drug. J Pharm Sci 2007; 9999: 1–13
   Google Scholar
• Sharma A, Pandey R, Sharma S, Khuller GK. Chemotherapeutic efficacy of poly (DL-lactide-co-glycolide) nanoparticle encapsulated antitubercular drugs at sub-therapeutic dose against experimental tuberculosis. Int. J Antimicrob Agents 2004; 24: 599–604
   PubMed Web of Science ®Google Scholar
• Zhu M, Namdar R, Stambaugh JJ, Starke JR, Bulpitt AE, Berning SE, Peloquin CA. Population pharmacokinetics of ethionamide in patients with tuberculosis. Tuberculosis 2002; 82: 91–6
   PubMed Web of Science ®Google Scholar
• Zweers MLT, Grijpma DW, Engbers GHM, Feijen J. The preparation of monodisperse biodegradable polyester nanopaticles with a controlled size. J biomed Mater Res Part B: Appl Biomater 2003; 66B: 559–66
   Google Scholar